Newborn Screening for Lysosomal Storage Diseases: Methodologies, Screen Positive Rates, Normalization of Datasets, Second-Tier Tests, and Post-Analysis Tools

All of the worldwide newborn screening (NBS) for lysosomal storage diseases (LSDs) is done by measurement of lysosomal enzymatic activities in dried blood spots (DBS). Substrates used for these assays are discussed. While the positive predictive value (PPV) is the gold standard for evaluating medica...

Descripción completa

Detalles Bibliográficos
Autor principal: Gelb, Michael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419971/
https://www.ncbi.nlm.nih.gov/pubmed/30882045
http://dx.doi.org/10.3390/ijns4030023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419971/
https://www.ncbi.nlm.nih.gov/pubmed/30882045
http://dx.doi.org/10.3390/ijns4030023

Ejemplares similares